Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Fungi
Reexamination Certificate
1999-09-24
2001-02-06
Tate, Christopher (Department: 1651)
Chemistry: molecular biology and microbiology
Micro-organism, per se ; compositions thereof; proces of...
Fungi
C435S254100, C435S254110, C435S069100, C435S173100
Reexamination Certificate
active
06184026
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to novel fungi having improved capacity for secretion recombinant polypeptides, and a method for improving such secretion.
2. Description of the Related Art
Filamentous fungi have become established as widely used host cell systems for the production of recombinant polypeptides. In many cases, however, fungi which have the desirable traits of ease of transformability and heterologous polypeptide expression do not necessarily have the most desirable characteristics for successful fermentation. For example, growth morphology during fermentation may not be optimal, since many cultures become quite viscous as biomass increases. Increased viscosity limits the ability to mix and aerate the fermentation culture, leading to oxygen and nutrient starvation of the mycelia, which in turn become inviable and unproductive limiting the yield of the polypeptide of interest. On the other hand, filamentous fungal strains showing good fermentation morphology are not necessarily the best production strains in terms of quantity of enzyme produced. Therefore, for commercial purposes, there is a need for filamentous fungal hosts which combine the capacity for expression of commercial quantities of recombinant polypeptide with satisfactory growth characteristics, such as rapid growth and low viscosity, thereby enhancing productivity during fermentation.
Screening of large numbers of mutants for improved fermentation morphology is quite difficult, and morphological mutant strains have often been isolated based on unusual colony morphology on solid medium. Traditionally, morphological mutants have been isolated in transformed strains that contain multiple copies of a heterologous gene. The mutants are then analyzed for fermentation growth characteristics and heterologous gene expression. Although this method may be useful in identifying improved expression strains, the relationship between any particular fungal growth morphology and a strain's ability to produce a large quantity of secreted polypeptide has yet to be established. Morphological mutants are also occasionally recovered in polypeptide expression improvement screens, following mutagenesis of a transformed strain, but again, the study of these strains has not led to any significant insight into the control of morphology. In addition, morphologically “improved” strains of parental strains containing heterologous gene expression cassettes are not suitable as general expression hosts since they cannot be used for the exclusive expression of other heterologous polypeptides.
It is an object of the present invention to provide methods for producing and identifying useful morphological mutants for heterologous polypeptide production.
SUMMARY OF THE INVENTION
The present invention relates to methods of obtaining a mutant cell from a filamentous fungal parent cell, comprising: (a) obtaining mutant cells of the parent cell; (b) identifying the mutant cell which exhibits a more restricted colonial phenotype and/or more extensive hyphal branching than the parent cell; and (c) identifying the mutant cell which has an improved property for production of a heterologous polypeptide than the parent cell, when the mutant and parent cells are cultured under the same conditions.
The invention also relates to mutant filamentous fungal cells produced by the methods of the present invention.
The present invention also relates to methods for producing a heterologous polypeptide, comprising: (a) culturing a mutant cell of the present invention which comprises a nucleic acid sequence encoding the heterologous polypeptide; and (b) recovering the heterologous polypeptide.
REFERENCES:
patent: 5578463 (1996-11-01), Berka et al.
patent: 5665585 (1997-09-01), Torkkeli et al.
Wösten et al., J. of General Microbiology, vol. 137, p. 2017-2023, 1991.
Wiebe et al., J. of General Microbiology, vol. 139, p. 2811-2817, 1993.
Springer et al., Genes & Development, vol. . 3, p. 559-571, 1989.
Rodrigues et al., Mycol. Res., vol. 95, No. 2, p. 163-177, 1991.
Pomés et al., FEMS Microbiology Letters, vol. 48, p. 255-259, 1997.
Withers et al., Mycol. Res., vol. 98, No. 1, p. 95-100, 1994.
Rosato et al., Rev. Brasil. Genet. A, vol. 3, p. 425-433, 1987.
Moscoso et al., Appl. Microbiology Biotechnology, vol. 26, p. 365-368, 1987.
Almeida et al., Trans. Br. Mycol. Soc., vol. 1, p. 139-143, 1984.
Banerjee et al., Can. J. Microbiol. vol. 27, p. 367-369, 1981.
Koide et al., J. Gen Appl. Micobiol. vol. 25, p. 161-168, 1979.
Simpson et al., J. of General Microbiology, vol. 110, p. 1-12, 1979.
Royer John C.
Shuster Jeffrey R.
Lambins Esq. Elias
Novo Nordisk Biotech Inc.
Starnes Robert L.
Tate Christopher
Zelson Esq. Steve
LandOfFree
Morphological mutants of filamentous fungi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Morphological mutants of filamentous fungi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Morphological mutants of filamentous fungi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2610470